Pall Launches New Fluid Management Technologies for the Biopharmaceutical Industry at INTERPHEX2007

The increasing focus on biotechnology and personalized medicines
along with the growth of the vaccine marketplace is changing the face
of the biopharmaceutical industry, an $80 billion global market. Drug
manufacturers are challenged by cost pressures, the need for shorter
production times and rapid scale-up, as well as bottlenecks in
downstream operations. At INTERPHEX2007, Pall Corporation (NYSE:PLL)
launches several new technologies to provide the biopharmaceutical
industry with tools and systems to more efficiently manage their
manufacturing processes. A leader in filtration, separation and
purification, Pall offers a comprehensive line of integrated solutions
for biopharmaceutical manufacturers from upstream to downstream
applications.

"In the rapidly changing biopharmaceutical market, manufacturers
must be able to adapt quickly and effectively to sustain leadership,"
says Ken Frank, President, Pall BioPharmaceuticals. "Our strong global
presence and deep portfolio of cutting-edge technologies provide
customers with comprehensive systems to help them efficiently optimize
their drug production processes."

Pall continues to champion the implementation of disposable
processing with the launch of its Allegro(TM) Systems, an integrated
single-use manufacturing solution, and its newest component, the
Allegro Biocontainers for collection and transport of process
solutions, product intermediates and cell culture media. Single-use
technologies, employed by more than 90 percent of biopharmaceutical
manufacturers, provide cost, flexibility and quality benefits. They
increase efficiency by eliminating the need for cleaning and cleaning
validation and reduce cross-contamination risks.

Pall Allegro Systems are gamma-irradiated and ready-for-use,
facilitating quick start-up and rapid scale-up to help accelerate
time-to-market. These qualities are becoming increasingly essential
for the production of biotech drugs and vaccines as well as for
contract manufacturing organizations.

The new Allegro Biocontainers feature a unique combination of
design and materials that help manufacturers maximize product recovery
and minimize risk of contamination. The comprehensive Allegro Systems
portfolio includes disposable filters, tubing and instant aseptic
connection devices in addition to the new biocontainers.

With the new disposable Kleenpak(TM) TFF Microfiltration Capsule,
Pall is introducing the industry's first tangential flow filtration
capsule. Tangential flow filtration is used for clarifying,
concentrating and purifying proteins. A self-enclosed capsule, the
Kleenpak TFF capsule helps improve worker safety by limiting exposure
to biologically active solutions. This is an important consideration
for manufacturers of vaccines and other potent products that present
potential workplace liabilities.

To address the processing bottlenecks caused by higher protein
throughput, Pall strengthens its line of ultrafiltration technologies
with the introduction of the Omega(TM) T- Series Membrane Cassettes.
The new cassettes are constructed with high performance materials that
reduce extractables and assure effective mass transfer of proteins to
deliver high-purity biological solutions. The advanced filtration
performance of the Omega T-Series cassettes is also available in a
disposable capsule format through the Minimate(TM) II Capsule. This
product easily scales with products in Pall's extensive line of
cassette technologies for truly integrated operations.

About Pall Corporation

Pall Corporation is the global leader in the rapidly growing field
of filtration, separation and purification. Pall is organized into two
businesses: Life Sciences and Industrial. These businesses provide
leading-edge products to meet the demanding needs of customers in
biotechnology, pharmaceutical, transfusion medicine, energy,
electronics, municipal and industrial water purification, aerospace,
transportation and broad industrial markets. Total revenues for fiscal
year 2006 were $2.0 billion. The Company headquarters is in East
Hills, New York with extensive operations throughout the world. For
more information visit Pall at www.pall.com.

Editor's Notes:

-- Pall's technologies are on display at INTERPHEX2007 booth #
1819, at the Jacob K. Javits Convention Center, New York, NY,
April 24-26, 2007.

-- Pall is hosting a press luncheon on Wednesday, April 25, 2007
at 12:00pm in room 1A18 at the Javits Convention Center.

-- Downloadable, high-resolution images are available at
http://www.pall.com/corporate_42872.asp.